Skip to main content
The C/C genotype of the C957T polymorphism of the dopamine D2 receptor (DRD2) is associated with schizophrenia
Schizophrenia Research (2005)
  • Bruce R Lawford
  • Ross McD Young
  • Christopher D Swagell
  • Mark Barnes
  • Simon C Burton
  • Warren K Ward
  • Karen R Heslop
  • Susan Shadforth
  • Angela van Daal, Queensland University of Technology
  • C Phillip Morris
The T allele of the human dopamine D2 receptor (DRD2) gene C957T polymorphism is associated with reduced mRNA translation and stability. This results in decreased dopamine induced DRD2 upregulation and decreased in vivo D2 dopamine binding. Conversely, the C allele of the C957T polymorphism is not associated with such changes in mRNA leading to increased DRD2 expression. PET and postmortem binding studies show that schizophrenia is often associated with increased DRD2 availability. We report that on the basis of comparing the frequencies of the C/C and T/T genotypes of 153 patients with schizophrenia and 148 controls that schizophrenia is associated with the C/C genotype. The C957T shows a population attributable risk for schizophrenia of 24% and an attributable risk in those with schizophrenia of 42%. Increased expression of D2 receptors associated with the C allele is likely to be important in the underlying pathophysiology of at least some forms of schizophrenia. Enhanced understanding of schizophrenia afforded by this finding may lead to advances in treatment and prevention.
  • Association,
  • dopamine,
  • D2 receptor,
  • genetic,
  • schizophrenia,
  • C957T
Publication Date
February 1, 2005
Citation Information
Bruce R Lawford, Ross McD Young, Christopher D Swagell, Mark Barnes, et al.. "The C/C genotype of the C957T polymorphism of the dopamine D2 receptor (DRD2) is associated with schizophrenia" Schizophrenia Research (2005)
Available at: